Ricardo Hernandez-Miramontes
Overview
Explore the profile of Ricardo Hernandez-Miramontes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barbosa-Mendez S, Matus-Ortega M, Hernandez-Miramontes R, Salazar-Juarez A
Hum Vaccin Immunother
. 2024 Jan;
20(1):2299068.
PMID: 38228468
Vaccination active, promising alternative immunological strategy to treat of CUD. Various models of cocaine vaccines have been evaluated in animals and humans with relative success. In this sense, it is...
2.
Barbosa-Mendez S, Matus-Ortega M, Hernandez-Miramontes R, Salazar-Juarez A
Int Immunopharmacol
. 2021 Jun;
98:107887.
PMID: 34186279
Clinical trials have indicated that a vaccine must be immunogenic in genetically diverse human populations and that immunogenicity and protective efficacy in animal models are two key indices required for...
3.
Barbosa-Mendez S, Matus-Ortega M, Hernandez-Miramontes R, Salazar-Juarez A
Hum Vaccin Immunother
. 2021 Jun;
17(10):3515-3528.
PMID: 34170784
Animal studies have reported the use of different opioid-vaccine formulations with relative success These studies have suggested that new opioid-vaccine formulations are required, which are capable of triggering a robust...
4.
Martinon S, Cisneros A, Villicana S, Hernandez-Miramontes R, Mixcoha E, Calderon-Vargas P
J Immunol Res
. 2019 Jun;
2019:3974127.
PMID: 31205956
Adjuvants are a diverse family of substances whose main objective is to increase the strength, quality, and duration of the immune response caused by vaccines. The most commonly used adjuvants...
5.
Barbosa-Mendez S, Leff P, Arias-Caballero A, Hernandez-Miramontes R, Heinze G, Salazar-Juarez A
J Psychiatr Res
. 2017 Apr;
92:38-46.
PMID: 28391178
Background: Relapse to cocaine use is a major problem in the clinical treatment of cocaine addiction. Antidepressants have been studied for their therapeutic potential to treat cocaine use disorder. Research...
6.
Salazar-Juarez A, Barbosa-Mendez S, Jurado N, Hernandez-Miramontes R, Leff P, Anton B
Prog Neuropsychopharmacol Biol Psychiatry
. 2016 Mar;
68:15-24.
PMID: 26922897
Cocaine abuse is a major health problem worldwide. Treatment based on both 5-HT2A/C and 5-HT3 receptor antagonists attenuate not only the effects of cocaine abuse but also the incentive/motivational effect...